Cite
HARVARD Citation
Huddart, R. et al. (n.d.). 915PLong term follow-up of the MRC TE23 randomized phase II trial of intensive induction chemotherapy (CBOP/BEP) in poor prognosis germ cell tumours (GCT) (CRUK/05/014; ISRCTN53643604). Annals of oncology. p. . [Online].